World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
39590
World Ranking
8536
National Ranking
337

Overview

Emile E. Voest is affiliated with Antoni van Leeuwenhoek Hospital in the Netherlands and has made significant contributions to medical research, particularly in oncology and related molecular biology fields. Their scholarly output spans publications focused on cancer research, immunology, and pulmonary and respiratory medicine.

The primary fields of study for Emile E. Voest include Medicine and Biochemistry, Genetics and Molecular Biology. Specific subfields of their work emphasize Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, and Immunology.

Key topics addressed in their research cover Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Genetic Factors in Colorectal Cancer, CAR-T Cell Therapy Research, and Radiomics and Machine Learning in Medical Imaging.

Frequent publication venues for Emile E. Voest include:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Nature Medicine
  • Clinical Cancer Research
  • Cancer Cell

The scientist has collaborated extensively with several peers, including Hans Gelderblom, Paul Roepman, Laurien J. Zeverijn, Henk M.W. Verheul, and Louisa R. Hoes.

Notable recent papers by Emile E. Voest include:

  • Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers, 2020, Nature Medicine
  • Caring for patients with cancer in the COVID-19 era, 2020, Nature Medicine
  • Delivering precision oncology to patients with cancer, 2022, Nature Medicine
  • Tumor organoids: Opportunities and challenges to guide precision medicine, 2021, Cancer Cell
  • Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer, 2024, New England Journal of Medicine

Best Publications

  • Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

    Jolien Tol;Miriam Koopman;Annemieke Cats;Cees J Rodenburg

  • A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

    Norman Sachs;Joep de Ligt;Oded Kopper;Ewa Gogola

  • Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

    Myriam Chalabi;Lorenzo F Fanchi;Krijn K Dijkstra;José G Van den Berg

  • Symptom prevalence in patients with incurable cancer: a systematic review.

    Saskia C.C.M. Teunissen;Wendy Wesker;Cas Kruitwagen;Hanneke C.J.M. de Haes

  • Long-term expanding human airway organoids for disease modeling

    Norman Sachs;Angelos Papaspyropoulos;Domenique D. Zomer-van Ommen;Inha Heo

  • Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

    Krijn K Dijkstra;Chiara M Cattaneo;Fleur Weeber;Myriam Chalabi

  • Inhibition of Angiogenesis In Vivo by Interleukin 12

    Emile E. Voest;Bärbel M. Kenyon;Michael S. O'Reilly;Gary Truitt

  • Pan-cancer whole-genome analyses of metastatic solid tumours

    Peter Priestley;Jonathan Baber;Martijn P. Lolkema;Neeltje Steeghs

  • Shared and separate functions of polo-like kinases and aurora kinases in cancer

    Susanne M. A. Lens;Emile E. Voest;René H. Medema

  • Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

    Wouter Scheper;Sander Kelderman;Lorenzo F. Fanchi;Carsten Linnemann

  • Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.

    Salo N. Ooft;Fleur Weeber;Krijn K. Dijkstra;Chelsea M. McLean

  • A model of angiogenesis in the mouse cornea.

    B M Kenyon;E E Voest;C C Chen;E Flynn

  • Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.

    Masatoshi Kuroki;Emile E. Voest;Emile E. Voest;Shiro Amano;Shiro Amano;Laurens V. Beerepoot;Laurens V. Beerepoot

  • Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents

    Yuval Shaked;Erik Henke;Jeanine M.L. Roodhart;Patrizia Mancuso

  • American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

    Lee M. Ellis;David S. Bernstein;Emile E. Voest;Jordan D. Berlin

  • Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.

    Fleur Weeber;Salo N. Ooft;Krijn K. Dijkstra;Emile E. Voest

  • Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

    Fleur Weeber;Marc van de Wetering;Marlous Hoogstraat;Krijn K Dijkstra

  • Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids

    Jeanine M.L. Roodhart;Laura G.M. Daenen;Edwin C.A. Stigter;Henk Jan Prins

  • Limitations and possibilities of small RNA digital gene expression profiling.

    Sam E V Linsen;Elzo de Wit;Georges Janssens;Sheila Heater

  • Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity

    Evelyne Beerling;Daniëlle Seinstra;Elzo de Wit;Elzo de Wit;Lennart Kester

Frequent Co-Authors

Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Edwin Cuppen
Edwin Cuppen Utrecht University
Stefan Sleijfer
Stefan Sleijfer Erasmus University Rotterdam
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Rachel H. Giles
Rachel H. Giles Utrecht University
Henk M.W. Verheul
Henk M.W. Verheul Radboud University
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Onno Kranenburg
Onno Kranenburg Utrecht University
Haiko J. Bloemendal
Haiko J. Bloemendal Radboud University
John B. A. G. Haanen
John B. A. G. Haanen Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond a traditional MD program, several affordable online degree options are available nationwide. These programs offer flexible pathways for students looking to enter in-demand fields within medicine and health services.

Students curious about health informatics may consider exploring online schools for health information management. These degrees prepare graduates to manage patient data, electronic health records, and crucial health information systems—skills that are increasingly vital in modern healthcare.

Those looking for a quick entry point into healthcare might explore a low cost medical coding and billing online program. This pathway helps students learn essential coding systems and billing procedures, opening doors to administrative roles in clinics, hospitals, and private practices.

For nurses seeking advanced roles, programs such as affordable np programs and accredited online nursing programs provide flexible options to earn higher degrees and credentials. These online pathways can lead to expanded career opportunities and increased earning potential.

Best Scientists Citing Emile E. Voest

Trending Scientists

Recently Published Articles